# Nicotinamide Riboside Supplementation in Chronic Kidney Disease

> **NCT07693543** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of California, San Diego** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide Riboside (NR)
- **DIETARY_SUPPLEMENT:** Matched Placebo (Capsules)

## Key facts

- **NCT ID:** NCT07693543
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2028-09-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07693543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07693543, "Nicotinamide Riboside Supplementation in Chronic Kidney Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07693543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*